IN THE NEWS

J. Blake Peart Joins VERTESS as Managing Director

Published December 10th 2021 Originally Published by Cision PR Newswire December 10th 2021

FORT WORTH, Texas, Dec. 10, 2021 /PRNewswire/ — VERTESS, a leading healthcare mergers and acquisitions (M+A) advisory firm (https://vertess.com), announced today that J. Blake Peart, a former hospital and Ambulatory Surgery Center (ASC) CEO, has joined the company as a Managing Director. Blake began his career as a clinician / Registered Respiratory Therapist (RRT) before moving into several administrative and executive positions with numerous high-profile healthcare organizations.

Blake has an extensive and diverse career in healthcare. In the past ten years, he has served as CEO for multiple hospitals of Fortune 500 companies and CEO for several large Ambulatory Surgery Centers. In addition, he has played a critical role in several M+A transactions, experiencing the entire M+A process from start to finish focusing primarily on private equity transactions. Blake's history as both a CEO and clinician provides him a unique perspective based on years of experience and empathy when working with business owners seeking M+A advice.

At VERTESS, Blake will provide M+A and consulting services primarily to Ambulatory Surgery Centers, Physician Practices, and independent hospital business markets, where he brings a level of expertise and depth of understanding rarely found in the healthcare M+A field.

"As someone who has walked in their shoes, I have chosen this path to support healthcare business owners who select the M+A direction," Blake stated. "I know that every transaction is unique and must be tailored to a seller's need in order to get the best deal. I am committed to providing a positive experience throughout the entire process. VERTESS and I are completely aligned in our goals and dedication to supporting our clients."

Brad Smith, VERTESS Managing Director/Partner, said, "We are honored to have Blake join our team. His far-reaching and respected career in healthcare provides him an advantage few in the healthcare M+A world can claim. Our clients have gained a formidable and compassionate ally in their journey through the transaction process."

J. Blake Peart can be reached directly at bpeart@vertess.com or +1.318.730-2435.

For questions about VERTESS, please contact Vaughne Glennie at 202-302-1621 or 325690@email4pr.com.

Continue Reading

MORE NEWS

Importance of Sellers Helping Buyers Reduce Healthcare Acquisition Integration Costs

Why should a buyer's costs of integrating an acquired company be of interest to the seller? The most important reason is...
Read More

Healthcare Private Equity Update Through First Half of 2024

Private equity often carries a negative connotation in the healthcare industry. However, if you are considering selling ...
Read More

10 Reasons Why Healthcare Mergers Fail (and How to Avoid Them)

At least seven out of 10. That's at the low end of how many mergers and acquisitions (M+As) are likely to fail. The high...
Read More

5 Ways To Increase the Financial Value of a Healthcare Company

Owners of healthcare companies are accustomed to creating financial value for their businesses by focusing on the tradit...
Read More

Moving Your Healthcare Company up the Growth Ladder

Most successful companies reach points in their history where big decisions must be made that will determine whether the...
Read More

Quality of Earnings: The Big Obstacle to Healthcare Deal Success

A lot of merger and acquisition (M+A) deals fail. That's been the case for a long time. The M+A failure rate that's freq...
Read More

VERTESS Answers: Why Do I Need to Market My Company to Buyers?

If you own a healthcare company, you are probably receiving inquiries from interested buyers. We view this as buyers mar...
Read More

6 Recommendations To Run a Better ASC and Achieve a Successful Sale

Preparing an ambulatory surgery center (ASC) for a sale is a worthwhile process for center owners regardless of whether ...
Read More

Hospital at Home: A Shift in the Healthcare System

We're seeing a notable shift occurring in healthcare. While we have largely focused on how to enhance care delivery with...
Read More

VERTESS Answers: Should I Work With a Healthcare Advisor or Broker?

We will occasionally hear from the owner of a healthcare company something along the lines of the following: "I know som...
Read More

Parallels Between Early Clinical and Early Transaction Intervention

My educational and professional experiences have demonstrated to me the importance and value of early intervention, both...
Read More

Corporate Transparency Act: What It Is and What You Need To Do

The Corporate Transparency Act (CTA) went into effect on Jan. 1, 2024. This federal reporting requirement affects millio...
Read More

Are You Ready to Sell Your Healthcare Company?

After spending many years building your healthcare company, it's increasingly likely that you will find yourself thinkin...
Read More

M&A Outlook: Active Start, Uncertain Future

Originally published by HME News on January 10, 2020 YARMOUTH, Maine – Building on a handful of notable deals in late...
Read More

Confidential Information Memorandum

Volume 9, Issue 24, November 21, 2022 There's the expression, "You never get a second chance to make a first impression....
Read More
1 2 3 41

COMMITTED TO CONSTANT IMPROVEMENT?

Want to stay current with trends in the medical/healthcare space as well as receive expert advice of veteran medical entrepreneurs?
SUBSCRIBE TO OUR BI-WEEKLY NEWSLETTER VERTESSPRESS
For over 10 years, we've been teaching ways you can improve the value of your healthcare company, focusing on informing you about mergers + acquisitions, including M+A trends in the healthcare market.
CHECK OUT VERTESSPRESS THE BLOG
No Spam Ever. We Promise
©2025 VERTESS. All Rights Reserved.